卵巢早衰患者血清相关激素水平的变化关系
摘要
关键词
全文:
PDF参考
[1] LIN J, LI X L, SONG H, et al. A general description for Chinese medicine in treating premature ovarian failure[J]. Chinese journal of integrative medicine,2017, 23(2): 91-97.
[2] Pal L, Santoro N. Premature ovarian failure (POF): discordance betweensomatic and reproductive aging. Ageing Res Rev. 2002 Jun;1(3):413-23.
[3] 曹志芳,张月红.补肾健脾中药联合穴位艾灸对卵巢早衰患者LH、E2、FSH 水平的影响及临床效果评价[J].实验与检验医学,2020,38(03):564-
565+577.
[4] Fang EF, Scheibye-Knudsen M, Jahn HJ, et al. A research agenda foraging in China in the 21st century[J]. Ageing Res Rev. 2015 Nov;24(Pt B):197-205.
[5] Huang Y, Hu C, Ye H, et al. Inflamm-Aging: A New Mechanism Af-fecting Premature Ovarian Insufficiency[J]. J Immunol Res. 2019 Jan 2;2019:8069898.
[6]Kirshenbaum M, Orvieto R. Premature ovarian insufficiency (POI) andautoimmunity-an update appraisal[J]. J Assist Reprod Genet. 2019 Nov;36(11):2207-2215.
[7] Aydogmus H, Kelekci S, Elmal1 F, et al. Can we use serum AntiMullerian hormone to differentiate the diagnosis between polycystic ovary syndrome patientsand healthy women with polycystic ovarian morphology and regular menstrual cycles[J]. Saudi Medical Journal,2018,39(10):1011-1016.
[8] 李美芝.多囊卵巢综合征的诊断与治疗[J].中华妇产科杂志,2002,37(7):444-446.
[9] Koninger A, Kampmeier A, Schmidt B, et al. Trends in anti -Müllerianhormone concentrations across different stages of pregnancy in women with poly-cystic ovary syndrome[J]. Reprod Biomed Online,2018,37(3):367-374.
[10]吕松林,李坤朋.曲普瑞林联合氯米芬对多囊卵巢综合征不孕患者促黄体生成素、促卵泡雌激素、睾酮水平的影响[J].临床医学研究与实践,2020,5(28):147-148.
Refbacks
- 当前没有refback。